- Home
- CABA vs AKA Comparison
CABA vs AKA Comparison
Compare CABA & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABA
- AKA
- Stock Information
- Founded
- CABA 2017
- AKA 2018
- Country
- CABA United States
- AKA United States
- Employees
- CABA N/A
- AKA N/A
- Industry
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- AKA Catalog/Specialty Distribution
- Sector
- CABA Health Care
- AKA Consumer Discretionary
- Exchange
- CABA Nasdaq
- AKA Nasdaq
- Market Cap
- CABA 118.8M
- AKA 126.7M
- IPO Year
- CABA 2019
- AKA 2021
- Fundamental
- Price
- CABA $1.55
- AKA $14.29
- Analyst Decision
- CABA Strong Buy
- AKA Buy
- Analyst Count
- CABA 8
- AKA 4
- Target Price
- CABA $26.13
- AKA $24.50
- AVG Volume (30 Days)
- CABA 801.5K
- AKA 12.4K
- Earning Date
- CABA 05-14-2025
- AKA 03-06-2025
- Dividend Yield
- CABA N/A
- AKA N/A
- EPS Growth
- CABA N/A
- AKA N/A
- EPS
- CABA N/A
- AKA N/A
- Revenue
- CABA N/A
- AKA $574,697,000.00
- Revenue This Year
- CABA $101.54
- AKA $5.39
- Revenue Next Year
- CABA N/A
- AKA N/A
- P/E Ratio
- CABA N/A
- AKA N/A
- Revenue Growth
- CABA N/A
- AKA 5.21
- 52 Week Low
- CABA $1.45
- AKA $8.89
- 52 Week High
- CABA $19.04
- AKA $33.73
- Technical
- Relative Strength Index (RSI)
- CABA 34.36
- AKA 50.11
- Support Level
- CABA $1.45
- AKA $12.02
- Resistance Level
- CABA $1.85
- AKA $16.90
- Average True Range (ATR)
- CABA 0.14
- AKA 0.93
- MACD
- CABA -0.00
- AKA 0.40
- Stochastic Oscillator
- CABA 17.86
- AKA 57.21
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.